| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANIP | Common Stock | Tax liability | $75,926 | -1,122 | -1.6% | $67.67 | 68,652 | 29 Feb 2024 | Direct | F1 |
| holding | ANIP | Common Stock | 882,620 | 29 Feb 2024 | Held by Esjay LLC | F2 | |||||
| holding | ANIP | Common Stock | 5,000 | 29 Feb 2024 | Held by SS Pharma LLC | F3 |
| Id | Content |
|---|---|
| F1 | Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported. |
| F2 | The reporting person holds voting and dispositive power over the shares held by Esjay LLC. |
| F3 | The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC. |